Results 1 to 10 of about 4,334 (159)

Ototoxicity Monitoring: The Evolution of a Protocol for Head and Neck Cancer Patients [PDF]

OTO Open
Objective We evaluated an ototoxicity monitoring program (OMP) for improving audiologic follow‐up in head and neck cancer (HNC) patients. Study Design Retrospective cohort study. Setting Tertiary academic center.
Jena Patel, Jacob Beiriger, Kalena Liu, Zach Urdang, Julia Croce, Molly Wolfson, Jacob Hulswit, Olivia Giglio, Jacob B. Hunter, Irina Middleton   +9 more
doaj   +5 more sources

Perspectives and practices of ototoxicity monitoring [PDF]

South African Journal of Communication Disorders, 2020
Background: Treatment of cancer with cisplatin can result in hearing loss. Given the increasing burden of cancer in Africa, appropriate and timely identification, intervention and management of hearing loss in affected patients is of paramount importance.
Jessica Paken, Cyril D. Govender, Mershen Pillay, Vikash Sewram   +3 more
doaj   +7 more sources

Ototoxicity monitoring in South African cancer facilities: A national survey [PDF]

South African Journal of Communication Disorders, 2022
Background: National information regarding ototoxicity monitoring practices are limited for patients undergoing chemotherapy in South Africa. Objectives: To determine (1) the national status of ototoxicity monitoring implemented in private and public ...
Katerina Ehlert, Barbara Heinze, De Wet Swanepoel   +2 more
doaj   +7 more sources

Insight into the current practice of ototoxicity monitoring during cisplatin therapy [PDF]

Journal of Otolaryngology - Head and Neck Surgery, 2021
Background The aim of this study is to evaluate the current state of ototoxicity monitoring for patients receiving cisplatin chemotherapy in an academic medical center with particular attention to how closely monitoring adheres to national ototoxicity ...
N. M. Santucci, B. Garber, R. Ivory, M. A. Kuhn, M. Stephen, D. Aizenberg   +5 more
doaj   +7 more sources

A Retrospective Evaluation of Ototoxicity Monitoring in a Cohort of Pediatric Patients With Solid Tumors, Treated in the Dutch National Cancer Center [PDF]

Cancer Reports
Introduction Ototoxicity is an adverse effect of childhood cancer treatment with a negative impact on speech‐language development and quality of life.
Franciscus A. Diepstraten, Odette M. M. Bertram, Hiske W. Helleman, Ralf A. Boerboom, Martine vanGrotel, József Zsíros, Godelieve A. M. Tytgat, Harm vanTinteren, Robert J. Stokroos, Geert O. Janssens, Alex E. Hoetink, Marry M. van denHeuvel‐Eibrink, Annelot J. M. Meijer   +12 more
doaj   +3 more sources

A longitudinal community-based ototoxicity monitoring programme and treatment effects for drug-resistant tuberculosis treatment, Western Cape [PDF]

South African Journal of Communication Disorders, 2022
Background: South Africa has a high burden of drug-resistant tuberculosis (DRTB) and until recently, ototoxic aminoglycosides were predominant in treatment regimens. Community-based ototoxicity monitoring programmes (OMPs) have been implemented for early
Lucia J. Stevenson, Leigh Biagio-de Jager, Marien A. Graham, De Wet Swanepoel   +3 more
doaj   +2 more sources

Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center

Audiology Research, 2023
Ototoxic drugs can result in hearing loss and tinnitus. Early detection of the ototoxic process can help minimize or prevent these consequences. The American Speech–Language–Hearing Association has provided guidelines for monitoring ototoxicity, whereas ...
Valeria Gambacorta, Eva Orzan, Mario Faralli, Mario Gullà, Ruggero Lapenna, Irene Baietta, Verena De Angelis, Giampietro Ricci   +7 more
doaj   +3 more sources

Statistical factors associated with utilisation of ototoxicity monitoring services for multi-drug-resistant tuberculosis patients in the Western Cape [PDF]

South African Journal of Communication Disorders, 2019
Background: South Africa is a high-burden multi-drug-resistant tuberculosis (MDR-TB) country. Previously, standard MDR-TB treatment regimen in South Africa included kanamycin, an aminoglycoside, which can cause permanent hearing loss in patients.
Lebogang Ramma, Primrose T. Nhokwara, Christine Rogers   +2 more
doaj   +2 more sources

Oncologists' views on ototoxicity monitoring in head and neck cancer patients: A South Indian qualitative study. [PDF]

PLoS ONE
AimThe perspectives and practices of healthcare professionals regarding ototoxicity in individuals with head and neck cancers are important for the implementation of ototoxicity monitoring. The current study aims to explore the oncologist's awareness and
Varsha Shankar, Jayashree Seethapathy, Satish Srinivas, Raghu Nandhan, Prasanna Kumar Saravanam   +4 more
doaj   +2 more sources

Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks—Narrative Review [PDF]

Diagnostics
Ototoxicity represents a clinically significant complication of anticancer therapy in pediatric patients. Cytotoxic agents used in oncology, particularly platinum-based chemotherapy, may induce damage to the auditory and vestibular systems, resulting in ...
Aleksandra Wojno, Oliwia Cichy, Agata Wojno, Karolina Dorobisz, Katarzyna Pazdro-Zastawny   +4 more
doaj   +2 more sources